Abstract
Ganglioside GM1 (NeuAc), labeled at the C-3 position of sphingosine with tritium, was injected into C3H/He, C57BL/10, B10.AQR mice intraperitoneally. The incorporation and the distribution of the radioactivity in various organs were examined. The injected [3H]GM1 (NeuAc) was mainly incorporated in the liver and hydrolyzed sequentially. Sialic acid of ganglioside GM1 (NeuAc) and metabolites was converted to N-glycolyl type from N-acetyl type. An appreciable amount of the sphingosine moiety in the administered GM1 (NeuAc), moreover, was reutilized, being converted to sphingomyelin, and incorpo-rated into alkyl chain of the ether lipid in phosphatidylethanolamine. The distributions of radioactivity in the metabolites of GM1 (NeuAc) administered to the three strains of mice were different from each other. In other organs, GM1 (NeuAc) was incorporated and metabolized only slightly. The N-methylamide, at the carboxyl group of the sialic acid, of the labeled ganglioside GM1 (GM1 (NeuAc)-NMe) was injected into C3H/He mice. Most of the administered [3H] GM1 (NeuAc)-NMe was incorporated in the liver, and was metabolized to GM3 (NeuAc)-NMe, via GM2 (NeuAc)-NMe, within 24 h. GM3 (NeuAc)-NMe was the only radioactive compound in the subsequent 10 weeks, but disappeared from the liver gradu-ally. N-Methylamide-modified gangliosides were resistant to hydrolysis by mouse hepatic sialidase, to elongation by glycosyltransferase and to N-glycolylation at N-acetyl-neuraminic acid by monooxygenase.
